| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |